1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Exosome diagnostic and therapeutic Market – By Application
1.3.2 Asia Pacific Exosome diagnostic and therapeutic Market – By Product
1.3.3 Asia Pacific Exosome diagnostic and therapeutic Market – By End User
1.3.4 Asia Pacific Exosome Diagnostic and Therapeutic Market – By Geography
2. Exosome Diagnostic And Therapeutic Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Exosome Diagnostic and Therapeutic Market – Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 Asia Pacific– PEST Analysis
5. Exosome Diagnostic and Therapeutic Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis
6. Exosome Diagnostic and Therapeutic Market Analysis – By Application
6.1 Overview
6.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
6.3 Diagnostic
6.3.1 Overview
6.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
6.4 Therapeutic
6.4.1 Overview
6.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
7. Exosome Diagnostic and Therapeutic Market Analysis – By Product
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
7.5 Software
7.5.1 Overview
7.5.2 Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8. Exosome Diagnostic and Therapeutic Market Analysis – By End User
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
8.3 Cancer Institutes
8.3.1 Overview
8.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.5 Diagnostic Centres
8.5.1 Overview
8.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.6 Other End User
8.6.1 Overview
8.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9. Exosome Diagnostic and Therapeutic Market – Country Analysis
9.1 Asia Pacific: Exosome Diagnostic and Therapeutic Market
9.1.1 Overview
9.1.2 Asia Pacific: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.3 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)
9.1.4 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.5 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.6 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
9.1.7 China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.7.1 China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.7.1.1 China: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.7.1.2 China: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.7.1.3 China: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.8 Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8.1 Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8.1.1 Japan: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.8.1.2 Japan: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.8.1.3 Japan: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.9 India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.9.1 India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.9.1.1 India: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.9.1.2 India: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.9.1.3 India: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.10 South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.10.1 South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.10.1.1 South Korea: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.10.1.2 South Korea: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.10.1.3 South Korea: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
9.1.11 Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1.1 Australia: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
9.1.11.1.2 Australia: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
9.1.11.1.3 Australia: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
10. Impact of COVID-19 Pandemic on Asia Pacific Exosome Diagnostic and Therapeutic Market
10.1 Asia-Pacific: Impact assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Cell Guidance Systems
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 BIOREGENERATIVE SCIENCES
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Evomic Science LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Norgen Biotek Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Miltenyi Biotec
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 AETHLON MEDICAL, INC
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 EXOSOME DIAGNOSTICS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms